Form 8-K - Current report:
SEC Accession No. 0001193125-16-788045
Filing Date
2016-12-08
Accepted
2016-12-08 08:45:32
Documents
2
Period of Report
2016-12-06
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d309997d8k.htm 8-K 64143
2 GRAPHIC g309997nimg6.jpg GRAPHIC 94294
  Complete submission text file 0001193125-16-788045.txt   195282
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

EIN.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35703 | Film No.: 162040431
SIC: 2834 Pharmaceutical Preparations